Stereotactic radiotherapy for nonsmall cell lung cancer

Current Opinion in Pulmonary Medicine

Volumn 14, Issue 4, 2008, Pages 297-302

  Ball, David ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Stage I nonsmall cell lung cancer; Stereotactic radiotherapy

Indexed keywords

CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGING; LUNG NON SMALL CELL CANCER; QUALITY CONTROL; RADIATION DOSE FRACTIONATION; REVIEW; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS AS TOPIC; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PATIENT SELECTION; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; STEREOTAXIC TECHNIQUES;

EID: 44849135934     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328302405a     Document Type: Review

References (49)

1. Kong F, Gaspar LE, Komaki R, et al. Patterns of practice in radiation dose prescription and treatment planning for patients with lung cancer among members of American Society of Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 2007; 69 (Suppl 1):S483.
2. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I nonsmall cell lung cancer: updated results of 257 patients in a Japanese multiinstitutional study. J Thorac Oncol 2007; 2 (suppl 3):S94-S100. Update of a large multiinstitution retrospective Japanese study which included medically operable patients; the main evidence underpinning a proposed trial of SRT versus surgery.
3. Fowler JF, Tome WA, Fenwick JD, et al. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 2004; 60:1241-1256.
4. Le QT, Loo BW, Ho A, et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 2006; 1:802-809.
5. Grau C, Hoyer M, Lindegaard J, et al. The emerging evidence for stereotactic body radiotherapy. Acta Oncol 2006; 45:771-774.
6. Horsman MR, Nielsen T, Ostergaard L, et al. Radiation administered as a large single dose or in a fractionated schedule: role of the tumour vasculature as a target for influencing response. ActaOncol 2006; 45:876-880.
7. Timmerman RD, Story M. Stereotactic body radiation therapy: a treatment in need of basic biological research. Cancer J 2006; 12:19-20.
8. Timmerman R, Galvin J, Michalski J, et al. Accreditation and quality assurance for Radiation Therapy Oncology Group: multicenter clinical trials using stereotactic body radiation therapy in lung cancer. Acta Oncol 2006; 45:779-786.
9. Li G, Citrin D, Camphausen K, et al. Advances in 4D medical imaging and 4D radiation therapy. Technol Cancer Res Treat 2008; 7:67-82.
10. Brown WT, Wu X, Amendola B, et al. Treatment of early nonsmall cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation: Cyber-Knife. Cancer J 2007; 13:87-94.
11. Collins BT, Erickson K, Reichner CA, et al. Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Radiat Oncol 2007; 2:39.
12. Yousefi S, Collins BT, Reichner CA, et al. Complications of thoracic computed tomography-guided fiducial placement for the purpose of stereotactic body radiation therapy. Clin Lung Cancer 2007; 8:252-256.
13. Underberg RW, Lagerwaard FJ, Slotman BJ, et al. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets. Int J Radiat Oncol Biol Phys 2005; 62:554-560.
14. Jin JY, Ajlouni M, Chen Q, et al. Quantification of incidental dose to potential clinical target volume (CTV) under different stereotactic body radiation therapy (SBRT) techniques for nonsmall cell lung cancer: tumor motion and using internal target volume (ITV) could improve dose distribution in CTV. Radiother Oncol 2007; 85:267-276.
15. Underberg RW, Lagerwaard FJ, van Tinteren H, et al. Time trends in target volumes for stage I nonsmall-cell lung cancer after stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 2006; 64:1221-1228.
16. Verellen D, Ridder MD, Linthout N, et al. Innovations in image-guided radiotherapy. Nat Rev Cancer 2007; 7:949-960. For those interested in the rapidly evolving technology underpinning SRT, an excellent review for the nonspecialist.
17. ••].
18. Gaspar LE. Stereotactic body radiation therapy for lung tumors: system-related issues and complications. Clin Lung Cancer 2007; 8:233.
19. McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early-stage nonsmall-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005; 63:1010-1015.
20. Koto M, Takai Y, Ogawa Y, et al. A phase II study on stereotactic body radiotherapy for stage I nonsmall cell lung cancer. Radiother Oncol 2007; 85:429-434. Rigorous phase II study.
21. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005; 63:1427-1431.
22. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24:4833-4839.
23. Hoyer M, Roed H, Hansen AT, et al. Prospective study on stereotactic radiotherapy of limited-stage nonsmall-cell lung cancer. Int J Radiat Oncol Biol Phys 2006; 66:S128-S135.
24. Senan S, Haasbeek NJ, Smit EF, et al. Stereotactic radiotherapy for centrally located early-stage lung tumors. J Clin Oncol 2007; 25:464; author reply 465.
25. Onimaru R, Shirato H, Shimizu S, et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003; 56:126-135.
26. Timmerman RD, Kavanagh BD, Cho LC, et al. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 2007; 25:947-952.
27. Guckenberger M, Heilman K, Wulf J, et al. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study. Radiother Oncol 2007; 85:435-442.
28. Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006; 45:787-795.
29. Fritz P, Kraus H-J, Muhlnickel W, et al. Stereotactic, single-dose irradiation of stage I nonsmall cell lung cancer and lung metastases. Radiat Oncol 2006; 1:30.
30. Xia T, Li H, Sun Q, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II nonsmall-cell lung cancer. Int J Radiat Oncol Biol Phys 2006; 66:117-125.
31. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) nonsmall-cell lung cancer (NSCLC). Acta Oncol 2006; 45:796-801.
32. Hof H, Muenter M, Oetzel D, et al. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer 2007; 110:148-155.
33. Onimaru R, Fujino M, Yamazaki K, et al. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys 2008; 70:374-381.
34. Wulf J, Baier K, Mueller G, et al. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 2005; 77:83-87.
35. Sinha B, McGarry RC. Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana University experience. Int J Radiat Oncol Biol Phys 2006; 66:1120-1124.
36. Fay M, Tan A, Fisher R, et al. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005; 61:1355-1363.
37. Fujino M, Shirato H, Onishi H, et al. Characteristics of patients who developed radiation pneumonitis requiring steroid therapy after stereotactic irradiation for lung tumors. Cancer J 2006; 12:41-46.
38. Paludan M, Traberg Hansen A, Petersen J, et al. Aggravation of dyspnea in stage I nonsmall cell lung cancer patients following stereotactic body radiotherapy: is there a dose-volume dependency? Acta Oncol 2006; 45:818-822.
39. Yamashita H, Nakagawa K, Nakamura N, et al. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2007; 2:21.
40. Bogart JA. Stereotactic body radiotherapy for poor-risk lung cancer: 'more cyber, less knife?'. Cancer J 2007; 13:75-77.
41. Kimura T, Matsuura K, Murakami Y, et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers? Int J Radiat Oncol Biol Phys 2006; 66:483-491.
42. Ohashi T, Takeda A, Shigematsu N, et al. Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors. Int J Radiat Oncol Biol Phys 2005; 62:1003-1008.
43. Lagerwaard FJ, Haasbeek CJA, Smit EF, et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008; 70:685-692.
44. Ricardi U, Guarneri A, Mantovani C, et al. Stereotactic body radiation therapy for early nonsmall cell lung cancer: experience at the University of Turin. J Thorac Oncol 2007; 2 (Suppl 1):S47.
45. Beitler JJ, Badine EA, El-Sayah D, et al. Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years. Int J Radiat Oncol Biol Phys 2006; 65:100-106.
46. Qiao X, Tullgren O, Lax I, et al. The role of radiotherapy in treatment of stage I nonsmall cell lung cancer. Lung Cancer 2003; 41:1-11.
47. Ball D, Withers HR. Stereotactic radiotherapy for stage I nonsmall-cell lung cancer: the triumph of technology over biology? Nat Clin Pract Oncol 2007; 4:614-615.
48. Nyman J, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I nonsmall cell lung cancer: mature results for medically inoperable patients. Lung Cancer 2006; 51:97-103.
49. Komaki R, Roth J. Introduction to stereotactic radiation therapy workshop. J Thorac Oncol 2007; 2 (Suppl 3):S93.